The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
PAK4 as a potential therapeutic target in pancreatic ductal adenocarcinoma (PDAC).
 
Kiruthikah Thillai
No Relationships to Disclose
 
Debashis Sarker
Honoraria - Pfizer; Pfizer (I)
Consulting or Advisory Role - Baxalta; Blueprint Medicines; Eisai (I); Ipsen (I); Novartis
Travel, Accommodations, Expenses - Bayer; ipsen
 
Claire Wells
No Relationships to Disclose